| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |